Why the study?
Does the automatic implantable cardioverter-defibrillator prevent sudden death in patients with drug-refractory ventricular tachyarrhythmias?
Population
78 patients with symptomatic, sustained ventricular tachyarrhythmias that were previously drug-refractory.
Comparison
Automatic implantable cardioverter-defibrillator… vs Amiodarone alone
Design
Cohort
Follow-up
1 and 2 years
Authors
Loading...
Supports ICD consideration in drug-refractory VT with syncope; leaves open randomized confirmation of survival benefit.
Does the automatic implantable cardioverter-defibrillator prevent sudden death in patients with drug-refractory ventricular tachyarrhythmias?
The automatic implantable cardioverter-defibrillator significantly reduces the risk of sudden death in patients with drug-refractory ventricular tachyarrhythmias who present with loss of consciousness.
Richard N. Fogoros (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: